annual accounts payable:
$14.22M+$2.23M(+18.58%)Summary
- As of today (June 30, 2025), ARQT annual accounts payable is $14.22 million, with the most recent change of +$2.23 million (+18.58%) on December 31, 2024.
- During the last 3 years, ARQT annual accounts payable has risen by +$6.87 million (+93.39%).
- ARQT annual accounts payable is now at all-time high.
Performance
ARQT Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$24.53M+$10.31M(+72.50%)Summary
- As of today (June 30, 2025), ARQT quarterly accounts payable is $24.53 million, with the most recent change of +$10.31 million (+72.50%) on March 31, 2025.
- Over the past year, ARQT quarterly accounts payable has increased by +$11.56 million (+89.14%).
- ARQT quarterly accounts payable is now at all-time high.
Performance
ARQT quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
ARQT Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +18.6% | +89.1% |
| 3 y3 years | +93.4% | +96.8% |
| 5 y5 years | +912.1% | +415.4% |
ARQT Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +93.4% | at high | +208.8% |
| 5 y | 5-year | at high | +912.1% | at high | +816.6% |
| alltime | all time | at high | +2548.0% | at high | +1645.8% |
ARQT Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $24.53M(+72.5%) |
| Dec 2024 | $14.22M(+18.6%) | $14.22M(-26.4%) |
| Sep 2024 | - | $19.32M(+143.3%) |
| Jun 2024 | - | $7.94M(-38.8%) |
| Mar 2024 | - | $12.97M(+8.1%) |
| Dec 2023 | $11.99M(+35.9%) | $11.99M(-9.0%) |
| Sep 2023 | - | $13.18M(-23.2%) |
| Jun 2023 | - | $17.16M(+37.4%) |
| Mar 2023 | - | $12.48M(+41.4%) |
| Dec 2022 | $8.83M | $8.83M(+1.9%) |
| Sep 2022 | - | $8.67M(+2.7%) |
| Jun 2022 | - | $8.44M(-32.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $12.47M(+69.5%) |
| Dec 2021 | $7.35M(+3.0%) | $7.35M(+51.0%) |
| Sep 2021 | - | $4.87M(+82.0%) |
| Jun 2021 | - | $2.68M(-14.9%) |
| Mar 2021 | - | $3.15M(-55.9%) |
| Dec 2020 | $7.14M(+408.2%) | $7.14M(+41.7%) |
| Sep 2020 | - | $5.04M(-38.9%) |
| Jun 2020 | - | $8.25M(+73.4%) |
| Mar 2020 | - | $4.76M(+238.7%) |
| Dec 2019 | $1.41M(-22.0%) | $1.41M(-55.5%) |
| Sep 2019 | - | $3.16M(+75.4%) |
| Dec 2018 | $1.80M(+235.4%) | $1.80M |
| Dec 2017 | $537.00K | - |
FAQ
- What is Arcutis Biotherapeutics annual accounts payable?
- What is the all time high annual accounts payable for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics annual accounts payable year-on-year change?
- What is Arcutis Biotherapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics quarterly accounts payable year-on-year change?
What is Arcutis Biotherapeutics annual accounts payable?
The current annual accounts payable of ARQT is $14.22M
What is the all time high annual accounts payable for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high annual accounts payable is $14.22M
What is Arcutis Biotherapeutics annual accounts payable year-on-year change?
Over the past year, ARQT annual accounts payable has changed by +$2.23M (+18.58%)
What is Arcutis Biotherapeutics quarterly accounts payable?
The current quarterly accounts payable of ARQT is $24.53M
What is the all time high quarterly accounts payable for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high quarterly accounts payable is $24.53M
What is Arcutis Biotherapeutics quarterly accounts payable year-on-year change?
Over the past year, ARQT quarterly accounts payable has changed by +$11.56M (+89.14%)